- Erratum
- Open Access
- Published:
Erratum to: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer
BMC Cancer volume 17, Article number: 569 (2017)
Erratum
After publication of the original article [1] the authors found that the case number “n” had been incorrectly marked for each Gleason group in Figure 1g (Fig. 1g).
ENDOD1 is downregulated in PCa tissues with high Gleason scores. a-f Representative images showed the ENDOD1 immunostaining intensity. BPH tissues showed negative (a) and moderate (b) ENDOD1 staining. PCa tissues showed negative (c), strong (d), and moderate (e) and weak (f) ENDOD1 staining, respectively. Magnification 200×. g, Immunoreactivity scores (IRS) analysis of ENDOD1 in BPH tissues and PCa tissues. IRS were determined by multiplying the level of staining intensity (negative = 0, weak = 1, moderate = 2, strong = 3) and percentage of positively stained cells (0% = 0, <10% = 1, 11–50% = 2, 51–80% = 3, >80% = 4). Results indicated that PCa tissues with higher Gleason scores (Gleason score ≥ 7) showed significantly lower ENDOD1 expression than that with low Gleason score and BPH tissues. *P<0.05; **P<0.01
The biopsy Gleason group information had been used in the original article:
BPH: n=30
GS≤6: n=25
GS=7: n=13
GS≥8: n=12
Data should instead have been taken from the post-operative Gleason group, and the figures should therefore appear as the following in Figure 1g:
BPH: n=30
GS≤6: n=22
GS=7: n=10
GS≥8: n=18
A corrected, full version of Figure 1 with the above amendments has been included in this Erratum.
Corrected Figure 1
Reference
Qiu J, Peng S, Si-Tu J, Hu C, Huang W, Mao Y, Qui W, Li K, Wang D. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer. BMC Cancer. 2017;17:360. doi:10.1186/s12885-017-3330-5.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s12885-017-3330-5
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Qiu, J., Peng, S., Si-Tu, J. et al. Erratum to: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer. BMC Cancer 17, 569 (2017). https://doi.org/10.1186/s12885-017-3517-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-017-3517-9